Where each statistic on the Qiri site comes from, and the caveat that limits how we use it. Most trace to a peer-reviewed paper, a government dataset or an international body. Where one is a media release, industry modelling or a market report, its entry says so. Where we publish our own modelling, the per-site projections, we list the inputs and assumptions. If a number doesn't add up, tell us.
Jump to: Australia United States New Zealand Global Regulatory Methodology
Backs the four problem-section statistics on qiri.ai/au, and the scope-of-practice figures in the Australian seed deck.
Backs the four problem-section statistics on qiri.ai/us, plus the workforce figure cited on /1995.
Backs the four problem-section statistics on qiri.ai/global.
Backs the regulatory pathway on qiri.ai/trust. Qiri Phase 1 is designed against these frameworks, and we claim no approval we have not obtained.
The per-site model behind the return-on-intelligence figures, worked separately for each market.
The return-on-intelligence figures on the locale pages come from a Qiri internal model built on public benchmarks, not from external literature. Australia and the United States are modelled separately, with different script volumes, different loaded wage rates, different currency, and only Australia carries funded clinical services. The two headline dollar figures are therefore built differently and should not be read against each other. The model is instrumented in live pilots now, and these figures are updated as pilot readouts land.
Inputs and arithmetic:
Market sizing (investor materials): global pharmacy management software and services is US$116.5B in 2026, growing to US$236.3B by 2031 at 15.2% CAGR, per Mordor Intelligence (July 2026), corroborated by The Business Research Company and 360iResearch; conservative scopes size the same category at US$34–53B. Clinical decision support software, the category Qiri’s reasoning layer competes in, reaches US$6.49B by 2030 at 13.1% CAGR across all care settings, per The Business Research Company (September 2026). For comparison, Heidi, the Melbourne-built AI scribe, raised US$340M (a US$100M Series C led by Blackbird plus US$240M of growth capital) at a US$900M valuation, reporting 2.8 million patient visits a week and ARR of US$50M as at April 2026, per its announcement of 22 September 2026. Dispensing labour: US pharmacies employ 321,970 pharmacists (mean wage US$140,920) and 471,680 pharmacy technicians (mean US$46,620), a combined wage bill of roughly US$67B a year, per BLS OEWS May 2025, occupation 29-1051 and 29-2052.
Backs the general-chatbot statistics on qiri.ai/ask-qiri. These figures describe general-purpose chatbots and AI search assistants, not purpose-built clinical software.
Backs the New Zealand framing on qiri.ai/nz. Its problem statistics are the global figures above, labelled as global, except the pharmacist wellbeing figure, which is New Zealand's own (nz-4).
If you have peer-reviewed data, regulator publications, or actuarial evidence we should be citing, share it. We update this page when better sources land.